Trials / Completed
CompletedNCT00649857
Food Study of Cetirizine HCl Tablets 10 mg and Zyrtec® 10 mg
Single-Dose Food In Vivo Bioequivalence Study of Cetirizine HCl Tablets (10 mg; Mylan) and Zyrtec® (10 mg; Pfizer) in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Mylan Pharmaceuticals Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to investigate the bioequivalence of Mylan's cetirizine HCl tablets to Pfizer's Zyrtec® tablets following a single, oral 10 mg (1 x 10 mg) dose administered under fed conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cetirizine HCl Tablets 10 mg | 10mg, single dose fed |
| DRUG | Zyrtec® 10 mg | 10mg, single dose fed |
Timeline
- Start date
- 2002-11-01
- Primary completion
- 2002-12-01
- Completion
- 2002-12-01
- First posted
- 2008-04-01
- Last updated
- 2024-04-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00649857. Inclusion in this directory is not an endorsement.